Results for tag: "TGFB1"

TGFB1 (transforming growth factor beta 1) is a protein involved in the regulation of cell growth, proliferation, differentiation, and apoptosis. It is a key player in the development of cancer, and is a target for oncology drugs. TGFB1 inhibitors are a class of drugs that block the activity of TGFB1, thus preventing the growth and spread of cancer cells. These drugs are used to treat a variety of cancers, including breast, lung, and colorectal cancer. TGFB1 inhibitors are a rapidly growing market, with many companies developing new drugs and treatments. Companies such as AstraZeneca, Merck, and Pfizer are leading the way in the development of TGFB1 inhibitors, with a focus on improving efficacy and safety. Other companies such as Novartis, Bristol-Myers Squibb, and Roche are also actively researching and developing TGFB1 inhibitors. Show Less Read more